Healthcare stock with revenue growth guidance of 207% for FY28 to keep an eye on

This Micro-cap Healthcare Stock, engaged in providing Ayurvedic healthcare solutions through a D2C model, offering natural wellness products for therapeutic and lifestyle needs via e-commerce, TV, and digital marketing, is in focus after the company announced a revenue growth guidance of 206.75 percent for FY28

With a market capitalization of Rs. 264.51 crore, the shares of Sat Kartar Shopping Limited were currently trading at Rs. 168 per equity share, down nearly 2.89 percent from its previous day’s close price of Rs. 173. 

Management Revenue Guidance:

Sat Kartar Shopping Ltd has outlined strong revenue growth plans for the next few years. The company aims for over Rs. 200 crore in FY26, reflecting an approximate 22.70 percent increase from FY25 revenue of Rs. 163 crore. Management believes this target is fully achievable, supported mainly by steady expansion in its product portfolio and rising market demand.

For the longer term, the company is targeting about Rs. 300 crore in FY27, indicating nearly 84.05 percent growth from FY25, and aspires to cross Rs. 500 crore in FY28, which represents 206.75 percent revenue growth. These goals are product-led, while upcoming hospital projects could add further momentum.

PAT and EBITDA Margin Guidance:

For FY26, Sat Kartar Shopping Limited is targeting a PAT margin of 9-10 percent, supported by steady sales growth and better cost control. Advertising expenses are expected to stay similar to current levels or reduce slightly by 100-200 bps, but management clarified that advertising will not be the main factor driving margins.

Looking ahead, the company expects stronger profitability, with FY27 EBITDA margins near 15 percent and PAT margins of 12-15 percent. By FY28, Sat Kartar Shopping Limited aims to exit the year with a PAT margin of 18-20 percent, reflecting improving scale and operational efficiencies.

Entry of Hospitals Business:

Sat Kartar Shopping Ltd is also expanding into healthcare with new Ayurveda hospital projects. The company plans to have 30 beds ready by Q1 FY27 and scale up to 300 operational beds by Q4 FY27. Each bed is expected to generate around Rs. 10,000 per day, with utilization rising to 80-90 percent about a year after operations begin. These hospitals are projected to deliver strong 25-30 percent EBITDA margins

The expansion will be funded entirely through internal accruals, and estimated capex per bed is Rs. 5-10 lakh, making the project relatively cost-efficient while supporting long-term growth in the healthcare segment.

Company Overview:

Sat Kartar Shopping Limited was incorporated on June 29, 2012 and is based in Delhi, India, and was founded by Mr Manprit Singh Chadha. The company was focused on delivering authentic Ayurvedic products and alternative medicine to promote natural healing for mind, body, and spirit.​

The company is engaged in the Ayurveda healthcare sector using a Direct-to-Consumer (D2C) model, blending traditional Ayurvedic principles from texts like Charak Samhita with modern research. 

Sat Kartar Shopping Limited follows an asset-light strategy, outsourcing manufacturing to partners while emphasizing product innovation, branding, marketing, and distribution through its website, third-party e-commerce, TV, and digital ads.

The company’s products include over 50 SKUs categorized into niche therapeutic solutions like Addiction Killer for quitting alcohol/tobacco, Liv Muztang capsules for personal care, Kaama Gold, and lifestyle items for slimming, hair care, gut health, PCOD, and mental wellness.

Recent quarter results:

Coming into financial highlights, Sat Kartar Shopping Limited’s revenue has increased from Rs. 76 crore in H1 FY25 to Rs. 88 crore in H1 FY26, which has grown by 15.79 percent. The net profit has also grown by 100 percent from Rs. 4 crore in H1 FY25 to Rs. 8 crore in H1 FY26.

Sat Kartar Shopping Limited’s revenue and net profit have grown at a CAGR of 46.35 percent and 115.44 percent, respectively, over the last three years.

In terms of return ratios, the company’s ROCE and ROE stand at 39.7 percent and 32 percent, respectively. Sat Kartar Shopping Limited has an earnings per share (EPS) of Rs. 8.75, and its debt-to-equity ratio is 0.04x.

Written By – Nikhil Naik

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Healthcare stock with revenue growth guidance of 207% for FY28 to keep an eye on appeared first on Trade Brains.